Zim Laboratories Ltd share price logo

Zim Laboratories Ltd (ZIMLAB)

₹108.271.8%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹106.1
    ₹110.5
  • 52 Week's Low

    52 Week's High

    ₹89.5
    ₹152.7
1 Month Return+ 4.21 %
3 Month Return+ 19.25 %
1 Year Return-9.67 %
Previous Close₹110.25
Open₹110.50
Volume3.98L
Upper Circuit-
Lower Circuit-
Market Cap₹537.20Cr

Key Statistics

P/E Ratio31.14
PEG Ratio-21.28
Market Cap₹537.20 Cr
P/B Ratio2.01
EPS0.68

Company Information

Zim Laboratories Ltd is a publicly-listed major player in India's pharmaceutical industry, working in the fields of antibiotics, antibacterials, analgesics, and more. The company was incorporated in Maharashtra in 1998, and quickly began business production. While the industry is dominated by multinationals and large Indian companies, Zim Laboratories come in as a strong presence in the lower end of the market; primarily, small-scale industrial (SSI) sector. This company provides customers with a vast range of branded and generic drugs of the highest standards.

Share Price: ₹108.27 per share as on 19 Jul, 2024 02:39 PM
Market Capitalisation: ₹537.20Cr as of today
Revenue: ₹117.86Cr as on March 2024 (Q1 24)
Net Profit: ₹8.09Cr as on March 2024 (Q1 24)
Listing date: 25 Nov, 2022
Chairperson Name: Anwar S Daud
OrganisationZim Laboratories Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Zim Laboratories Ltd

  • Zim Laboratories Reports Decrease in Revenue and Net Income - 12 Jun, 2024

    Zim Laboratories reported a 7.8% decrease in revenue, with net income down by 29% and profit margin decreasing from 6.1% to 4.7% in FY 2024. EPS also decreased from ₹5.02 to ₹3.54. The Outside India segment contributed 78% of total revenue. Zim Laboratories shares are up 7.0% from a week ago.

  • ZIM Laboratories' Accrual Ratio Indicates Lower Free Cash Flow - 21 May, 2024

    An article suggests that ZIM Laboratories' free cash flow was significantly lower than its statutory profit, with a negative free cash flow of ₹576m over the last year. The company's earnings per share have grown impressively in the last three years, but investors are advised to analyze risks and warnings before investing.

  • ZIM Lab Reports Increase in Net Sales and Quarterly Net Profit - 17 May, 2024

    ZIM Lab's standalone net sales for March 2024 increased by 12.39% YoY, with a quarterly net profit of Rs. 7.89 crore, up 10.51% from the previous year. The company's EPS has also increased to Rs. 1.62 in March 2024. However, ZIM Lab shares have given negative returns of -5.65% over the last six months.

Insights on Zim Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 68.56 Cr → 119.4 Cr (in ₹), with an average increase of 16.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 0.23 Cr → 8.09 Cr (in ₹), with an average increase of 49.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 131.3% return, outperforming this stock by 152.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 33.26% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 95.2% return, outperforming this stock by 104.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ZIMLAB stock has moved down by -20.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 66.73% to 66.63% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.01% to 0.00% in Jun 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹117.86Cr
↑22.40%
Net Income
₹8.09Cr
↑69.25%
Net Profit Margin
6.86%
↑38.31%
2024Y/Y Change
Revenue
₹367.42Cr
↓7.81%
Net Income
₹17.25Cr
↓29.39%
Net Profit Margin
4.69%
↓23.49%
Value in ₹ crore
2024Y/Y Change
Total Assets
₹443.72Cr
↑30.86%
Total Liabilities
₹211.76Cr
↑46.13%
Value in ₹ crore
2024Y/Y Change
Operating Cash Flow
₹11.47Cr
↓67.44%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
33.26%
0.00
Foreign Institutions
0%
-47.37
Mutual Funds
0%
0.00
Retail Investors
66.63%
-0.16
Others
0.11%
0.00

Key Indicators

Zim Laboratories Ltd Valuation

Zim Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.12x)

June 11, 2018

Today (31.14x)

July 18, 2024

Industry (57.08x)

July 18, 2024

Highest (198.80x)

July 1, 2021

LowHigh

Earnings and Dividends

  • Zim Laboratories Ltd Earnings Results

    Zim Laboratories Ltd’s net profit jumped 11.74% since last year same period to ₹8.09Cr in the Q4 2023-2024. On a quarterly growth basis, Zim Laboratories Ltd has generated 69.25% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Zim Laboratories Ltd Dividends May,2019

    In the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.36%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Zim Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Zim Laboratories Ltd shares.

Zim Laboratories Ltd (ZIMLAB) share price today is ₹108.27

Zim Laboratories Ltd is listed on NSE

Zim Laboratories Ltd is listed on BSE

  • Today’s highest price of Zim Laboratories Ltd is ₹110.5.
  • Today’s lowest price of Zim Laboratories Ltd is ₹106.1.

PE Ratio of Zim Laboratories Ltd is 31.14

PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share

Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 3.98L.

Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹537.2Cr.

Zim Laboratories Ltd(ZIMLABPrice
52 Week High
₹152.7
52 Week Low
₹89.5

Zim Laboratories Ltd(ZIMLAB) share price is ₹108.27. It is down -29.10% from its 52 Week High price of ₹152.7

Zim Laboratories Ltd(ZIMLAB) share price is ₹108.27. It is up 20.97% from its 52 Week Low price of ₹89.5

Zim Laboratories Ltd(ZIMLABReturns
1 Day Returns
-1.98%
1 Month Returns
4.21%
3 Month Returns
19.25%
1 Year Returns
-9.67%